These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36528792)

  • 1. RNA Editing is a Valuable Biomarker for Predicting Carcinogenesis in Ulcerative Colitis.
    Takahashi K; Shigeyasu K; Kondo Y; Gotoh K; Yano S; Umeda Y; Inokuchi T; Xu C; Yoshida K; Umeda H; Takahashi T; Takeda S; Yoshida R; Teraishi F; Kishimoto H; Mori Y; Noma K; Okugawa Y; Hiraoka S; Michiue H; Tazawa H; Matsushita O; Goel A; Fujiwara T
    J Crohns Colitis; 2023 May; 17(5):754-766. PubMed ID: 36528792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
    Okugawa Y; Toiyama Y; Shigeyasu K; Yamamoto A; Shigemori T; Yin C; Ichikawa T; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Araki T; Kusunoki M; Goel A
    J Transl Med; 2018 Dec; 16(1):366. PubMed ID: 30563560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer.
    Takeda S; Shigeyasu K; Okugawa Y; Yoshida K; Mori Y; Yano S; Noma K; Umeda Y; Kondo Y; Kishimoto H; Teraishi F; Nagasaka T; Tazawa H; Kagawa S; Fujiwara T; Goel A
    Cancer Lett; 2019 Mar; 444():127-135. PubMed ID: 30583079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAR1 and AZIN1 RNA editing function as an oncogene and contributes to immortalization in endometrial cancer.
    Nakamura K; Shigeyasu K; Okamoto K; Matsuoka H; Masuyama H
    Gynecol Oncol; 2022 Aug; 166(2):326-333. PubMed ID: 35697535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer.
    Shigeyasu K; Okugawa Y; Toden S; Miyoshi J; Toiyama Y; Nagasaka T; Takahashi N; Kusunoki M; Takayama T; Yamada Y; Fujiwara T; Chen L; Goel A
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
    Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y
    RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
    Liu Y; Wolff KC; Jacobs BL; Samuel CE
    Virology; 2001 Oct; 289(2):378-87. PubMed ID: 11689059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosis.
    Vlachogiannis NI; Tual-Chalot S; Zormpas E; Bonini F; Ntouros PA; Pappa M; Bournia VK; Tektonidou MG; Souliotis VL; Mavragani CP; Stamatelopoulos K; Gatsiou A; Sfikakis PP; Stellos K
    J Autoimmun; 2021 Dec; 125():102755. PubMed ID: 34857436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma.
    Qin YR; Qiao JJ; Chan TH; Zhu YH; Li FF; Liu H; Fei J; Li Y; Guan XY; Chen L
    Cancer Res; 2014 Feb; 74(3):840-51. PubMed ID: 24302582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing.
    Liu G; Ma X; Wang Z; Wakae K; Yuan Y; He Z; Yoshiyama H; Iizasa H; Zhang H; Matsuda M; Sugiyama R; Yuan Z; Muramatsu M; Li L
    J Biol Chem; 2019 Sep; 294(38):14043-14054. PubMed ID: 31366735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicle‑mediated RNA editing may underlie the heterogeneity and spread of hepatocellular carcinoma in human tissue and
    Shibata C; Otsuka M; Shimizu T; Seimiya T; Kishikawa T; Aoki T; Fujishiro M
    Oncol Rep; 2023 Nov; 50(5):. PubMed ID: 37732519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1).
    George CX; John L; Samuel CE
    J Interferon Cytokine Res; 2014 Jun; 34(6):437-46. PubMed ID: 24905200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation.
    Jiang L; Park MJ; Cho CJ; Lee K; Jung MK; Pack CG; Myung SJ; Chang S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.
    Mannion NM; Greenwood SM; Young R; Cox S; Brindle J; Read D; Nellåker C; Vesely C; Ponting CP; McLaughlin PJ; Jantsch MF; Dorin J; Adams IR; Scadden AD; Ohman M; Keegan LP; O'Connell MA
    Cell Rep; 2014 Nov; 9(4):1482-94. PubMed ID: 25456137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Widespread inosine-containing mRNA in lymphocytes regulated by ADAR1 in response to inflammation.
    Yang JH; Luo X; Nie Y; Su Y; Zhao Q; Kabir K; Zhang D; Rabinovici R
    Immunology; 2003 May; 109(1):15-23. PubMed ID: 12709013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA editing facilitates the enhanced production of neoantigens during the simultaneous administration of oxaliplatin and radiotherapy in colorectal cancer.
    Komatsu Y; Shigeyasu K; Yano S; Takeda S; Takahashi K; Hata N; Umeda H; Yoshida K; Mori Y; Yasui K; Yoshida R; Kondo Y; Kishimoto H; Teraishi F; Umeda Y; Kagawa S; Michiue H; Tazawa H; Goel A; Fujiwara T
    Sci Rep; 2022 Aug; 12(1):13540. PubMed ID: 35941214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAR1-dependent miR-3144-3p editing simultaneously induces MSI2 expression and suppresses SLC38A4 expression in liver cancer.
    Kim HS; Na MJ; Son KH; Yang HD; Kim SY; Shin E; Ha JW; Jeon S; Kang K; Moon K; Park WS; Nam SW
    Exp Mol Med; 2023 Jan; 55(1):95-107. PubMed ID: 36599932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
    Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
    Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer.
    Hata N; Shigeyasu K; Umeda Y; Yano S; Takeda S; Yoshida K; Fuji T; Yoshida R; Yasui K; Umeda H; Takahashi T; Kondo Y; Kishimoto H; Mori Y; Teraishi F; Yamamoto H; Michiue H; Nakamura K; Tazawa H; Fujiwara T
    Sci Rep; 2023 Feb; 13(1):2078. PubMed ID: 36747029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA Editing by ADAR Adenosine Deaminases: From Molecular Plasticity of Neural Proteins to the Mechanisms of Human Cancer.
    Goncharov AO; Kliuchnikova AA; Nasaev SS; Moshkovskii SA
    Biochemistry (Mosc); 2019 Aug; 84(8):896-904. PubMed ID: 31522671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.